AB 1794: Pharmacy: enteral nutrition supplements or replacements.

Official summary

Legislative Counsel’s Digest (official, as of the latest version). Written by nonpartisan legislative staff; reproduced verbatim.

Existing law, the Pharmacy Law, requires the California State Board of Pharmacy within the Department of Consumer Affairs to license and regulate the practice of pharmacy, including pharmacists, pharmacy technicians, and pharmacies. Under existing law, it is unlawful for any person to manufacture, compound, furnish, sell, or dispense a dangerous drug or dangerous device, or to dispense or compound a prescription unless they are licensed, as specified. Existing law authorizes the distribution of drugs and devices directly to dialysis patients pursuant to regulations adopted by the board and other specified conditions.

This bill would also authorize a pharmacist, manufacturer, or wholesaler to participate in an arrangement or agreement to deliver enteral nutrition supplements or replacements directly to a patient’s residence pursuant to a valid order from a prescriber acting within their scope of practice, and in accordance with the services and activities provided by a pharmacist, consistent with the accepted standard of care, as specified. For these purposes, the bill would define “enteral nutrition supplements or replacements” to mean medical food used as a therapeutic regimen to prevent serious disability or death in patients with medically diagnosed conditions that preclude the full use of regular food. The bill would also make nonsubstantive changes to existing provisions.

Sponsors

Sponsors by party (alphabetical): Democratic 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. September 27, 2026Chaptered by Secretary of State - Chapter 546, Statutes of 2026.
2. September 27, 2026Approved by the Governor.
3. August 31, 2026Enrolled and presented to the Governor at 4 p.m.
4. August 25, 2026Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 6465.).
5. August 24, 2026In Assembly. Concurrence in Senate amendments pending.
6. August 24, 2026Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0.).
7. June 30, 2026Read second time. Ordered to third reading.
8. June 29, 2026From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
9. June 15, 2026From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (June 15). Re-referred to Com. on APPR.
10. June 8, 2026From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
11. May 20, 2026Referred to Com. on B. P. & E.D.
12. May 12, 2026In Senate. Read first time. To Com. on RLS. for assignment.